Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer

K. Fizazi; N. Tran; L. Fein; N. Matsubara; A. Rodriguez-Antolin; B.Y. Alekseev; M. Özgüroglu; D. Ye; S. Feyerabend; A. Protheroe; P. De Porre; T. Kheoh; Y.C. Park; M.B. Todd; K.N. Chi; Ugo De Giorgi

doi:10.1056/NEJMoa1704174

Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer

K. Fizazi, N. Tran, L. Fein, N. Matsubara, A. Rodriguez-Antolin, B.Y. Alekseev, M. Özgüroglu, D. Ye, S. Feyerabend, A. Protheroe, P. De Porre, T. Kheoh, Y.C. Park, M.B. Todd, K.N. Chi, Ugo De Giorgi

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Research output: Contribution to journal › Article › peer-review

Original language	Italian
Pages (from-to)	352-360
Number of pages	9
Journal	New England Journal of Medicine
Volume	377
Issue number	4
DOIs	https://doi.org/10.1056/NEJMoa1704174
Publication status	Published - 2017

Access to Document

10.1056/NEJMoa1704174

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020848493&doi=10.1056%2fNEJMoa1704174&partnerID=40&md5=562cc8e6f555f7574c4b4259900f18bd

Cite this

Fizazi, K., Tran, N., Fein, L., Matsubara, N., Rodriguez-Antolin, A., Alekseev, B. Y., Özgüroglu, M., Ye, D., Feyerabend, S., Protheroe, A., De Porre, P., Kheoh, T., Park, Y. C., Todd, M. B., Chi, K. N., & De Giorgi, U. (2017). Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer. New England Journal of Medicine, 377(4), 352-360. https://doi.org/10.1056/NEJMoa1704174

Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer. / Fizazi, K.; Tran, N.; Fein, L.; Matsubara, N.; Rodriguez-Antolin, A.; Alekseev, B.Y.; Özgüroglu, M.; Ye, D.; Feyerabend, S.; Protheroe, A.; De Porre, P.; Kheoh, T.; Park, Y.C.; Todd, M.B.; Chi, K.N.; De Giorgi, Ugo.

In: New England Journal of Medicine, Vol. 377, No. 4, 2017, p. 352-360.

Research output: Contribution to journal › Article › peer-review

Fizazi, K, Tran, N, Fein, L, Matsubara, N, Rodriguez-Antolin, A, Alekseev, BY, Özgüroglu, M, Ye, D, Feyerabend, S, Protheroe, A, De Porre, P, Kheoh, T, Park, YC, Todd, MB, Chi, KN & De Giorgi, U 2017, 'Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer', New England Journal of Medicine, vol. 377, no. 4, pp. 352-360. https://doi.org/10.1056/NEJMoa1704174

Fizazi, K. ; Tran, N. ; Fein, L. ; Matsubara, N. ; Rodriguez-Antolin, A. ; Alekseev, B.Y. ; Özgüroglu, M. ; Ye, D. ; Feyerabend, S. ; Protheroe, A. ; De Porre, P. ; Kheoh, T. ; Park, Y.C. ; Todd, M.B. ; Chi, K.N. ; De Giorgi, Ugo. / Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer. In: New England Journal of Medicine. 2017 ; Vol. 377, No. 4. pp. 352-360.

@article{d6860dff539b47ce8a28134a69c23a11,

title = "Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer",

author = "K. Fizazi and N. Tran and L. Fein and N. Matsubara and A. Rodriguez-Antolin and B.Y. Alekseev and M. {\"O}zg{\"u}roglu and D. Ye and S. Feyerabend and A. Protheroe and {De Porre}, P. and T. Kheoh and Y.C. Park and M.B. Todd and K.N. Chi and {De Giorgi}, Ugo",

note = "Cited By :55 Export Date: 12 February 2018",

year = "2017",

doi = "10.1056/NEJMoa1704174",

language = "Italian",

volume = "377",

pages = "352--360",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "4",

}

TY - JOUR

T1 - Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer

AU - Fizazi, K.

AU - Tran, N.

AU - Fein, L.

AU - Matsubara, N.

AU - Rodriguez-Antolin, A.

AU - Alekseev, B.Y.

AU - Özgüroglu, M.

AU - Ye, D.

AU - Feyerabend, S.

AU - Protheroe, A.

AU - De Porre, P.

AU - Kheoh, T.

AU - Park, Y.C.

AU - Todd, M.B.

AU - Chi, K.N.

AU - De Giorgi, Ugo

N1 - Cited By :55 Export Date: 12 February 2018

PY - 2017

Y1 - 2017

U2 - 10.1056/NEJMoa1704174

DO - 10.1056/NEJMoa1704174

M3 - Articolo

VL - 377

SP - 352

EP - 360

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 4

ER -